scientist 35: the biotechnologist – Difinigen clone liver cells for pharmacology (2013)

We talk to Dr Marcus Yeo about how human cell production benefits drug development. Dr Yeo is from DifiniGEN, a Cambridge company that grows liver cells used to test if new drugs are harmful. Their technology comes from the Nobel Prize-winning work of Cambridge university’s Sir John Gurdon. The ability to grow special cells from stem cells also offers the possibility for organ replacement in the future.

Follow-up link:

• DifiniGEN definigen.com

18/02/2013 

Podcast: Play in new window

more: Google Podcasts | Spotify | RSS | subscribe options